I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers

NCT05986071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: M1774
DRUG: Fulvestrant injection

Sponsor

Institut Paoli-Calmettes

Collaborators

[object Object]
[object Object]